The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen
 
Consulting or Advisory Role - AstraZeneca; Roche Pharma AG
Impact of trebananib plus weekly paclitaxel on overall survival (OS) in patients (pts) with recurrent ovarian cancer and ascites: Results from the phase III TRINOVA-1 study.
 
Bradley J. Monk
No Relationships to Disclose
 
Andres Poveda
Consulting or Advisory Role - AstraZeneca; PharmaMar; Roche Pharma AG
 
Ignace Vergote
Consulting or Advisory Role - Amgen
Research Funding - Amgen (Inst)
 
Francesco Raspagliesi
No Relationships to Disclose
 
Keiichi Fujiwara
Honoraria - Chugai Pharma; Eisai; Kyowa Hakko Kirin; Nippon Kayaku; Taiho Pharmaceutical; Zeria Pharmaceutical
Consulting or Advisory Role - Arno Therapeutics; Chugai Pharma; GlaxoSmithKline
Research Funding - Chugai Pharma (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Johnson & Johnson (Inst); Kaken Pharmaceutical (Inst); Pfizer (Inst); Sanofi (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Yakult Honsha (Inst)
 
Duk-Soo Bae
Consulting or Advisory Role - Zeria Pharmaceutical
 
Ana Oaknin
No Relationships to Disclose
 
Isabelle Ray-Coquard
Research Funding - PharmaMar; Roche Pharma AG
Travel, Accommodations, Expenses - AstraZeneca; Novartis; Roche Pharma AG
 
Diane M. Provencher
Leadership - AstraZeneca
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Roche/Genentech
 
Beth Y. Karlan
Patents, Royalties, Other Intellectual Property - Patent Pending
 
Catherine Lhommé
No Relationships to Disclose
 
Gary Richardson
Research Funding - Amgen; Roche Pharma AG
 
Dolores Gallardo Rincon
No Relationships to Disclose
 
Robert L. Coleman
Honoraria - NCCN
Consulting or Advisory Role - Clovis Oncology; Esperance Pharmaceuticals; Genentech/Roche
Research Funding - Amgen; Array BioPharma; AstraZeneca/MedImmune; Clovis Oncology; Esperance Pharmaceuticals; Johnson & Johnson; Merrimack; OncoMed
Travel, Accommodations, Expenses - Amgen; Array BioPharma; AstraZeneca/MedImmune; Gradalis; Merck; Merrimack; Millennium
 
Arija Brize
No Relationships to Disclose
 
Kathy Zhang
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Florian D. Vogl
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Bruce A. Bach
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Amit M. Oza
Consulting or Advisory Role - Amgen; Clovis Oncology; Verastem
Research Funding - AstraZeneca; Immunogen; Immunovaccine; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche